Learning Objectives:

1. Review pathophysiology of JAK-STAT pathway and how this can be implicated in sarcoidosis 

2. Discuss current literature of JAK inhibitors in sarcoidosis treatment with focus on cutaneous and pulmonary sarcoidosis

 

Session date: 
11/12/2024 - 8:30am to 9:30am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Asha Asthana, MD